CB8411 has cytoprotective and neuroprotective properties. It has been shown to exhibit activity in a relevant proof-of-concept disease model for memory loss which is directly related to the situation in humans. The drug exhibits a novel mechanism of action. It will be used for the treatment of dementia, and attention-deficit hyperactivity disorder (ADHD).